Yes I think it is a buy as it drifts lower. Seems well managed on a shareholder friendly basis. Sakura Sogo is doing better lately increasing the chance of a Gjt style resolution.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025